CompletedNCT00043654
Mifepristone for depression in bipolarity
About this title
Clinical Trial of Mifepristone for Bipolar Depression
Read the official source — NCT00043654Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateAugust 7, 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 110
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00043654
- Official title
Show the full official title
Antiglucocorticoid Therapy in Bipolar Depression With Mifepristone (RU486)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Mifepristone.
Who was this study for?
Listed age limits: 18 years to 75 years.
